GENEREX TO COLLABORATE WITH EUROPEAN COMPANY

Generex Biotechnology Corporation today announced that a research collaboration agreement has been signed by its subsidiary Antigen Express with Stallergenes, S.A. a major European firm in immunological treatments for allergy and asthma. The studies are to design and test Ii-Key/allergen epitope hybrid peptides to create a novel approach for the control of both dangerous forms of asthma and functionally disabling allergic reactions. A large number of individuals in both North America and Europe suffer from various forms of allergic responses.

PharmaLive (http://www.pharmalive.com/News/index.cfm?articleid=250618&categoryid=15)